Lower-middle-market private equity group Seacoast Capital Managers LLC invested $30 million worth of syndicated growth equity for a noncontrolling stake in Illinois-based Skincure Oncology LLC.
The investment was used to aid a shareholder dividend and capitalize SkinCure for future growth.
Founded in 2016, SkinCure provides management services and solutions to dermatologists and a noninvasive alternative for treating nonmelanoma skin cancer.
